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The Galectins are a family of proteins that share an affinity
for Beta-galactoside containing glycoconjugates. Galectin-
3 has been implicated in tumor progression and metasta-
sis. It is also known that in prostate, ovarian and breast
cancer, down regulation of Galectin-3 is associated with
malignancy. Kaposi's sarcoma (KS) is characterized as an
angioproliferative tumor of vascular endothelial cells and
produces rare B cell lymphoproliferative diseases in the
form of primary effusion lymphomas (PEL) and some
forms of Multicentric Castleman's Disease (MDC).
Kaposi's Sarcoma-Associated Herpesvirus also known as
KSHV or Human Herpesvirus type 8 (HHV8) is the etio-
logical agent of KS. We have observed suppression of
galectin-3 expression in Kaposi's sarcoma (KS). Here we
demonstrate that galectin-3 protein expression is down-
regulated 20-fold in KSHV infected dermal microvascular
endothelial cells (DMVEC) cells. We show loss of Galec-
tin-3 staining by dual labeled immunofluorescence in
latency associated nuclear antigen (LANA) positive spin-
dle cells. We also find reduced levels of galectin-3 expres-
sion in LANA positive spindle cell regions in archival KS
tissue. There is also transcriptional suppression of Galec-
tin-3 message in KSHV infected DMVEC cells compared to
mock infected controls. We demonstrate that KSHV vFLIP
is the likely viral gene that targets galectin-3 downregula-
tion in HeLa cells. In pleural effusion lymphoma cell lines
(PEL), we observe different levels of galectin-3 expression
associated with varying levels of KSHV replication. The
search for novel host cell factors that may contribute to
the overall pathogenesis of KS is essential for early detec-
tion of KS and development of innovative therapies for
treatment.
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